Literature DB >> 406271

Functional delineation of hyperprolactinemic-amenorrhea.

G C Lachelin, S Abu-fadil, S S Yen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 406271     DOI： 10.1210/jcem-44-6-1163

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  10 in total

1.  Hypothalamic-pituitary-ovarian function in hyperprolactinemic women.

Authors:  P Travaglini; B Ambrosi; P Beck-Peccoz; R Elli; M Rondena; R Bara; G Weber
Journal:  J Endocrinol Invest       Date:  1978-01       Impact factor: 4.256

2.  The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP.

Authors:  D K Grandy; M Litt; L Allen; J R Bunzow; M Marchionni; H Makam; L Reed; R E Magenis; O Civelli
Journal:  Am J Hum Genet       Date:  1989-11       Impact factor: 11.025

3.  Serum LH increase after estradiol and progesterone administration in hyperprolactinemic women.

Authors:  P Travaglini; R Elli; B Ambrosi; M Ballabio; P Moriondo; G Faglia
Journal:  J Endocrinol Invest       Date:  1979 Oct-Dec       Impact factor: 4.256

4.  [Hyperprolactinemia and sterility].

Authors:  H K Rjosk; R Fahlbusch; K von Werder
Journal:  Arch Gynecol       Date:  1979-07-20

5.  Diagnostic value of thyrotropin-releasing-hormone stimulation in patients with pituitary tumor.

Authors:  D M Cook; M A Greer; H Paxton
Journal:  West J Med       Date:  1987-08

Review 6.  Diagnosis and management of prolactinomas.

Authors:  J R Dollar; R E Blackwell
Journal:  Cancer Metastasis Rev       Date:  1986       Impact factor: 9.264

Review 7.  [Human prolactin (author's transl)].

Authors:  K von Werder; H K Rjosk
Journal:  Klin Wochenschr       Date:  1979-01-01

8.  Prolactin-secreting pituitary adenomas.

Authors:  M C Martin; E D Schriock; R B Jaffe
Journal:  West J Med       Date:  1983-11

Review 9.  Leptin and leptin receptor in anterior pituitary function.

Authors:  R V Lloyd; L Jin; I Tsumanuma; S Vidal; K Kovacs; E Horvath; B W Scheithauer; M E Couce; B Burguera
Journal:  Pituitary       Date:  2001 Jan-Apr       Impact factor: 4.107

10.  Metabolic abnormalities in patients with prolactinoma: response to treatment with cabergoline.

Authors:  Nazir A Pala; Bashir A Laway; Raiz A Misgar; Rayees A Dar
Journal:  Diabetol Metab Syndr       Date:  2015-11-14       Impact factor: 3.320
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.